ClinVar Miner

Submissions for variant NM_003640.5(ELP1):c.3937G>A (p.Glu1313Lys)

dbSNP: rs1554735745
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001861910 SCV002282164 uncertain significance not provided 2021-08-31 criteria provided, single submitter clinical testing
Ambry Genetics RCV004025162 SCV002755116 uncertain significance not specified 2022-02-02 criteria provided, single submitter clinical testing The p.E1313K variant (also known as c.3937G>A), located in coding exon 36 of the IKBKAP gene, results from a G to A substitution at nucleotide position 3937. The glutamic acid at codon 1313 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Natera, Inc. RCV000693675 SCV001452809 uncertain significance Familial dysautonomia 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.